CSTL - CASTLE BIOSCIENCES INC

QQQ $ 480.33 $ -0.97 (-0.2 %)

DIA $ 407.90 $ -1.21 (-0.3 %)

SPY $ 558.48 $ -0.68 (-0.12 %)

TLT $ 98.53 $ 0.23 (0.23 %)

GLD $ 232.40 $ -1.32 (-0.56 %)

Previous Close

$ 27.96

Open

$ 27.98

Bid

$ 27.78 x 100

Ask

-- x --

Day's Range

$ 27.34 - $ 27.98

52 Week Range

$ 12.07 - $ 28.56

Volume

769,871

Average Volume

Market Cap

803.51M

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-03-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-02-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-08-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-10-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-09-2020	09-30-2020	10-Q
17	08-10-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-10-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	09-03-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

yum-china-posts-upbeat-earnings-joins-clear-secure-tg-therapeutics-bioventus-and-other-big-stocks-moving-higher-on-tuesday

Yum China Posts Upbeat Earnings, Joins Cle...
08/06/2024 15:47:18

Stephens & Co. Reiterates Overweight on Ca...
08/06/2024 15:44:26

Stephens & Co. analyst Mason Carrico reiterates Castle Biosciences (NASDAQ:CSTL) with a Overweight and maintains $37 pri...

Baird Maintains Outperform on Castle Biosc...
08/06/2024 10:44:51

Baird analyst Catherine Ramsey maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and raises the price target from...

Castle Biosciences Increases FY24 Revenue ...
08/05/2024 20:59:31

Castle Biosciences Q2 2024 GAAP EPS $0.31 ...
08/05/2024 20:13:04

Castle Biosciences (NASDAQ:CSTL) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $(...

on-semiconductor-posts-upbeat-earnings-joins-oil-states-international-commscope-holding-and-other-big-stocks-moving-higher-on-monday

ON Semiconductor Posts Upbeat Earnings, Jo...
07/29/2024 15:09:55

top-5-health-care-stocks-that-may-explode-in-july

Top 5 Health Care Stocks That May Explode ...
07/08/2024 12:40:10

why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Why NIO Shares Are Trading Lower By Over 8...
07/05/2024 16:59:40

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

Baird Maintains Outperform on Castle Biosc...
07/05/2024 16:53:18

Baird analyst Catherine Ramsey maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and maintains $34 price target.

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
06/19/2024 20:30:52

Castle Biosciences Presents New Data Highl...
05/30/2024 21:01:03

Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of pa...

Castle Biosciences Announces Publication O...
05/29/2024 20:32:22

In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test,...

Castle Biosciences Expands Evidence Suppor...
05/14/2024 11:07:01

Castle Biosciences Announced Data From Stu...
05/08/2024 22:42:10

Castle Biosciences Says New Data Supportin...
05/03/2024 11:13:15

Baird Maintains Outperform on Castle Biosc...
05/03/2024 10:56:48

Baird analyst Catherine Ramsey maintains Castle Biosciences (NASDAQ:CSTL) with a Outperform and raises the price target from...

Castle Biosciences Increases FY23 Revenue ...
05/02/2024 21:34:58

Castle Biosciences Q1 2024 GAAP EPS $(0.09...
05/02/2024 20:33:47

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(...

Castle Biosciences Plans To Share New Data...
04/04/2024 20:31:51

Castle Biosciences Gives Long-Term Outcome...
03/22/2024 20:34:44

Castle's second presentation at SSO 2024 shows that in a study of 979 patients, DecisionDx-Melanoma demonstrated clinical u...